GLUTAPRO Trademark

Trademark Overview


On Tuesday, December 10, 2024, a trademark application was filed for GLUTAPRO with the United States Patent and Trademark Office. The USPTO has given the GLUTAPRO trademark a serial number of 98894829. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, April 8, 2025. This trademark is owned by Tesseract Medical Research, LLC. The GLUTAPRO trademark is filed in the Pharmaceutical Products category with the following description:

Dietary supplements; nutritional supplements; dietary supplements and nutritional supplements containing glutamine; pharmaceutical preparation, namely glutamine being a dietary ingredient manufactured by a proprietary process that results in glutamine being absorbed in the intestinal tract in a time-dependent manner; pharmaceutical feature in the nature of a sustained-release delivery ingredient in the nature of dietary supplements and nutritional supplements, made in whole or significant part from glutamine, sold as an integral component of dietary supplements and nutritional supplements for supporting detoxification pathways, immune function, cellular metabolism, tissue repair, wound healing, and healthy aging.
glutapro

General Information


Serial Number98894829
Word MarkGLUTAPRO
Filing DateTuesday, December 10, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, April 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 8, 2025

Trademark Statements


Goods and ServicesDietary supplements; nutritional supplements; dietary supplements and nutritional supplements containing glutamine; pharmaceutical preparation, namely glutamine being a dietary ingredient manufactured by a proprietary process that results in glutamine being absorbed in the intestinal tract in a time-dependent manner; pharmaceutical feature in the nature of a sustained-release delivery ingredient in the nature of dietary supplements and nutritional supplements, made in whole or significant part from glutamine, sold as an integral component of dietary supplements and nutritional supplements for supporting detoxification pathways, immune function, cellular metabolism, tissue repair, wound healing, and healthy aging.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 10, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTesseract Medical Research, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLaguna Hills, CA 92653

Party NameTesseract Medical Research, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLaguna Hills, CA 92653

Trademark Events


Event DateEvent Description
Tuesday, December 10, 2024NEW APPLICATION ENTERED
Tuesday, February 25, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 25, 2025NON-FINAL ACTION E-MAILED
Tuesday, February 25, 2025NON-FINAL ACTION WRITTEN
Tuesday, December 10, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 18, 2025ASSIGNED TO EXAMINER
Wednesday, March 5, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 5, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 5, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 12, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 2, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 8, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 8, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED